Don't Ignore The Insider Selling In Pulmonx
Don't Ignore The Insider Selling In Pulmonx
We note that the Pulmonx Corporation (NASDAQ:LUNG) CEO, President & Director, Glendon French, recently sold US$69k worth of stock for US$10.34 per share. However we note that the sale only shrunk their holding by 0.7%.
我們注意到,普爾蒙克斯公司(納斯達克股票代碼:LUNG)首席執行官、總裁兼董事格倫登·法蘭西最近以每股10.34美元的價格出售了價值6.9萬美元的股票。但是,我們注意到,此次出售僅使他們的持股量減少了0.7%。
View our latest analysis for Pulmonx
查看我們對 Pulmonx 的最新分析
Pulmonx Insider Transactions Over The Last Year
Pulmonx 過去一年的內幕交易
In fact, the recent sale by CEO, President & Director Glendon French was not their only sale of Pulmonx shares this year. Earlier in the year, they fetched US$11.49 per share in a -US$75k sale. So it's clear an insider wanted to take some cash off the table, even below the current price of US$11.77. As a general rule we consider it to be discouraging when insiders are selling below the current price, because it suggests they were happy with a lower valuation. However, while insider selling is sometimes discouraging, it's only a weak signal. It is worth noting that this sale was only 0.7% of Glendon French's holding.
實際上,首席執行官、總裁兼董事格倫登·法蘭西最近出售的股票並不是他們今年唯一一次出售Pulmonx股票。今年早些時候,他們以-7.5萬美元的價格出售了每股11.49美元。因此,很明顯,一位內部人士想從牌桌上提取一些現金,甚至低於目前的11.77美元的價格。通常,當內部人士以低於當前價格的價格出售時,我們認爲這會令人沮喪,因爲這表明他們對較低的估值感到滿意。但是,儘管內幕拋售有時令人沮喪,但這只是一個微弱的信號。值得注意的是,此次出售僅佔Glendon French持股量的0.7%。
Pulmonx insiders didn't buy any shares over the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
去年,Pulmonx內部人士沒有購買任何股票。你可以在下面看到過去 12 個月內幕交易(由公司和個人進行的)的直觀描述。如果您想確切地知道誰售出、售價多少、何時出售,只需點擊下圖即可!
![insider-trading-volume](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20231208/0-dbadee9ec79e80e5d5f13290e89feb9c-0-edc1509b3317589e4e594bc6c39c416b.png/big)
For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.
對於那些喜歡尋找中獎投資的人來說,這份最近有內幕收購的成長型公司的免費名單可能只是門票。
Does Pulmonx Boast High Insider Ownership?
Pulmonx 是否擁有很高的內幕所有權?
For a common shareholder, it is worth checking how many shares are held by company insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. It appears that Pulmonx insiders own 4.0% of the company, worth about US$18m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.
對於普通股股東來說,值得檢查一下公司內部人士持有多少股票。通常,內部人所有權越高,內部人士被激勵長期建立公司的可能性就越大。看來Pulmonx內部人士擁有該公司4.0%的股份,價值約1800萬美元。儘管這是內部人所有權強勁但並不突出的水平,但這足以表明管理層與小股東之間有一定的一致性。
So What Does This Data Suggest About Pulmonx Insiders?
那麼,這些數據對Pulmonx Insiders有何啓示呢?
Insiders sold Pulmonx shares recently, but they didn't buy any. Looking to the last twelve months, our data doesn't show any insider buying. Insider ownership isn't particularly high, so this analysis makes us cautious about the company. We'd practice some caution before buying! So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. You'd be interested to know, that we found 3 warning signs for Pulmonx and we suggest you have a look.
業內人士最近出售了Pulmonx的股票,但他們沒有買入任何股票。展望過去的十二個月,我們的數據並未顯示任何內幕買盤。內部所有權並不是特別高,因此這種分析使我們對公司持謹慎態度。在購買之前,我們會謹慎行事!因此,儘管了解內部人士在買入或賣出方面的所作所爲很有幫助,但了解特定公司面臨的風險也很有幫助。你可能會感興趣地知道,我們發現了 Pulmonx 的 3 個警告信號,我們建議你看看。
Of course Pulmonx may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
當然,Pulmonx可能不是最值得買入的股票。因此,您可能希望看到這些免費的高質量公司集。
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
就本文而言,內部人士是指向相關監管機構報告其交易的個人。我們目前只考慮公開市場交易和私下處置的直接利益,不包括衍生品交易或間接權益。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。